Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» PF-05280014
PF-05280014
Pfizer's Herceptin biosimilar succeeds in key breast cancer study
Yahoo/Reuters
Wed, 11/30/16 - 09:44 pm
Pfizer
biosimilars
Herceptin
PF-05280014
HER2-positive metastatic breast cancer